BENCHMARK PROFILE
Strand Bio
Latest sync: Sep 8, 2026, 8:55 AM. Source coverage currently reflects PB Evidence data.
Readers using the 29 retained price observations as a dated comparison and sourcing current pricing and testing documentation directly.
The audited public markup exposed no detectable third-party testing evidence to evaluate. Catalog pages are now in the public evidence sweep after the researcher-login route migrated to the public catalog, but the retained prices are not a restamped anonymous quote, and price comparability is not evidence of identity or purity. Anyone weighing current pricing or testing should request the relevant documentation directly and judge it on its own terms.
Included for its retained pricing record. PeptideBenchmark previously captured 29 directly comparable rows from Strand Bio’s public price list; those accepted rows remain as a dated comparison because PeptideBenchmark has not restamped them as a new anonymous quote. The September 7 public-markup audit detected no Strand Bio testing evidence on 83 reachable research, compliance, and catalog pages after the researcher-login route migrated to the public catalog, while otherwise unlabelled raster image pixels remain outside that claim.
PeptideBenchmark retains 29 formerly public catalog records, each with one vial size and one accepted price, so the dated range still normalizes to $/mg without a deferral. Catalog HTML is now publicly reachable after the researcher-login route migrated to the public catalog; PeptideBenchmark has not restamped those August 15 rows as a new anonymous quote. On September 7, PeptideBenchmark checked 83 publicly reachable research, compliance, and catalog pages, fourteen exact certificate-route 404s, and 1 exact authentication gate reached from public links: the partner feed returned its reviewed 401 approved-researcher response after the researcher-login route migrated to the public catalog. It found no certificate, purity figure, batch identifier, laboratory name, or verification code in the audited public markup. Otherwise unlabelled image pixels were not inspected.
The bounded September 7 audit found no certificates of analysis, purity results, batch identifiers, laboratory names, or verification codes in Strand Bio’s public research, compliance, and catalog markup. PeptideBenchmark checked 83 reachable pages and fourteen conventional certificate routes; none served a public PDF document. Of 1 exact authentication gate reached from public links, the partner feed returned its reviewed 401 approved-researcher response after the researcher-login route migrated to the public catalog. Otherwise unlabelled image pixels are outside this finding. Detectable testing language on public pages appeared only in reviewed comparison or policy context.
This vendor is one of 113 names currently included in our manual curated research-vendor layer.
PB Curated Assessment is a PeptideBenchmark-authored rubric built from the trust and transparency review layer. It is separate from the source-derived benchmark score.
Strand Bio is curated because it matters to the coverage set, but the current public evidence layer is still early or incomplete.
The current public trust surface is still thin or unresolved.
We do not yet have enough verification structure to treat this as a strong transparency case.
Current review has not yet established broad product-level evidence depth.
The current evidence layer is still thin on clearly named outside-lab context.
Score 1.0 from pb evidence score.
PB Curated Assessment: Early. This is our own trust/transparency rubric and is kept separate from the PB score.
Under the formula retired on Aug 28, 2026 this vendor scores 1.15 — under the evidence-first formula it is unranked until verifiable evidence exists. What changed and why: scoring methodology.
Observed from public domain records and the vendor's own site on Aug 27, 2026. Identity facts are shown for context and do not affect scores.
We hold no certificates for this vendor yet.Send it to the archive →
Same third-party review signals shown on the vendor board. Click Trustpilot or Pep Review Pro to open the source profile.
PB score is the number you should read first on this page. It starts with trust evidence, pricing coverage, and third-party review signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available. Reviewed transparency evidence contributes a bounded amount — shown as a trust lift for source-benchmarked vendors, and folded into the base score for PB-evidence vendors.
This vendor’s score is evidence-first: verifiable testing evidence forms the backbone, and outside review sources are a bounded adjustment that can warn far more than it can boost. The terms below sum to the displayed score (small rounding aside). Full formula on the scoring methodology page.
Insufficient verifiable evidence to score. This vendor is unranked rather than assigned a number; review signals remain displayed above.
WHAT THIS PAGE IS
- Board-ranked vendor profile with source-linked benchmark inputs
- No Finnrick score currently linked
- No Peptide Critic score currently linked
- No Trustpilot profile currently linked
- No Pep Review Pro profile currently linked
CURRENT LIMITS
- Not an original lab test or editorial review
- Source scales and methodologies differ across sites
- Depends on source site freshness and formatting
METHODOLOGY
How to read this benchmark
This profile summarizes public benchmark data synced from Finnrick and, when available, Peptide Critic. Finnrick contributes a 10-point average from its vendor table, while Peptide Critic contributes a 5-star rating that we normalize to a 10-point scale before ranking consensus entries.
A high score can be directionally useful, but it is not a substitute for current COAs, identity testing, chain-of-custody details, or your own due diligence. We are intentionally separating source aggregation from first-party editorial claims.
Scores combine PB trust evidence with external signals from Finnrick, Peptide Critic, Trustpilot, and Pep Review Pro when available.